B H Doft, M Barza. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Amikacin/adverse effectsAmikacin/therapeutic useAnimalsCeftazidime/adverse effectsCeftazidime/therapeutic useDrug ToleranceEndophthalmitis/drug therapyEndophthalmitis/microbiologyEye Infections, Bacterial/drug therapyHumansPostoperative Complications/drug therapyPostoperative Complications/microbiologyRabbitsVitreous Body
Substances: See more » AmikacinCeftazidime
Year: 1994 PMID: 8285881 DOI: 10.1001/archopht.1994.01090130027002
Source DB: PubMed Journal: Arch Ophthalmol ISSN: 0003-9950